Abivax SA American Depositary Shares (ABVX) Financials
Key financial figures for Abivax SA American Depositary Shares (Q4 2025), as reported in EUR.
Abivax S.A. reported revenue of 0.00 EUR for Q4 FY2025, down 100.0% from the same period a year earlier. The company posted a net loss of 287.7 million EUR, or -2.10 EUR per share. Across the last 5 reported quarters, quarterly revenue has moved from 2.3 million EUR in Q4 FY2023 to 0.00 EUR in Q4 FY2025. The figures above are as filed, and the full income statement, balance sheet and cash flow history for Abivax S.A. are on the SentiSense financials page.
- Revenue
- EUR 0
- Net Income
- -EUR 288M
- EPS
- EUR -2.10
- Total Assets
- EUR 652M
- Operating Cash Flow
- -EUR 71M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q4 FY2025 | EUR 0 | -EUR 288M | -EUR 2.10 | ||
| Q2 FY2025 | EUR 0 | -EUR 48M | -EUR 1.59 | -EUR 33M | |
| Q4 FY2024 | EUR 0 | -EUR 52M | -EUR 1.50 | -EUR 33M | |
| Q2 FY2024 | EUR 0 | -EUR 39M | -EUR 0.65 | -EUR 51M | |
| Q4 FY2023 | EUR 2M | -EUR 96M | -EUR 1.98 | -3975.15% | -EUR 71M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | EUR 0 | -EUR 336M | -EUR 4.65 | -EUR 156M | |
| FY2024 | EUR 0 | -EUR 176M | -EUR 2.80 | -EUR 155M | |
| FY2023 | EUR 0 | -EUR 148M | -EUR 3.43 | -EUR 100M |
Frequently asked questions
What was Abivax S.A.'s revenue last quarter?
Abivax S.A. reported revenue of 0.00 EUR for Q4 FY2025, down 100.0% from the same period a year earlier.
Is Abivax S.A. profitable?
Not in its most recent reported period. Abivax S.A. reported a net loss of 287.7 million EUR for Q4 FY2025.
When does Abivax S.A. report next?
Abivax S.A. is scheduled to report results on 2026-09-21. The company has confirmed that date.
Figures are as reported by the filer in EUR and are not converted to US dollars. The share price is quoted in US dollars, so the two are not directly comparable.
Full income statement, balance sheet and cash flow for Abivax SA American Depositary Shares on SentiSense, with up to forty quarters and twenty fiscal years of history.